During your consultation, we will review your health history, discuss your goals, and design a personalized peptide therapy plan to help you achieve optimal health and vitality.
GHK-Cu concentrations in human plasma decline with age: approximately 200 ng/mL at age 20, dropping to 80 ng/mL by age 60
Official Website: ascend-biolabs.com The company states that its products are synthesized, tested, packaged, and shipped entirely within the United States
Corvol, K
FDA just moved the GLP1 peptide supply chain from a background compliance issue to a frontline border action
Nrf2, which is usually bound to Keap1 by ubiquitination or degraded by Keap1 in the absence of oxidative stress, is translocated to the nucleus when oxidative stress modifies the conformational structure of Keap1 and prevents it from binding Nrf2 (Komaravelli and Casola, 2014